TCTR20230821003尚未招募3 期
Efficacy of infraorbital darkening treatment using multi-pulsed Q-switched 1064-nm Nd:YAG laser
none0 个研究点目标入组 15 人开始时间: 2023年8月21日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30 Years 至 60 Years（—）
- 性别
- All
入选标准
- •Healthy patient with a history of infraorbital darkening diagnosed by dermatologist at least 1 year
- •- Fitzpatrick skin type II to IV
排除标准
- •- Signs of active infection or inflammation around the eyes
- •- Diseases related to infraorbital darkening
- •- Active systemic severe medical diseases/ photosensitivity such as liver cirrhosis, thalassemia, systemic lupus erythematosus and dermatomyositis
- •- Drug-induced hyperpigmentation such as hydroxychloroquine, chloroquine, gold or zidovudine
- •- History of any ocular or periocular surgery e.g. blepharoplasty or treatment of fat herniation
- •- History of abnormal wound healing process such as poor controlled diabetes mellitus or smoking
- •- History of atopy
- •- Pregnancy and lactation
- •- Immunocompromised host/status
- •- Sleep disorders such as sleep disturbance or narcolepsy
- •- Use of oral retinoids within 6 months
- •- Use of nonsteroidal antiinflammatory drugs, steroids, anticoagulants, blood thinning agents and topical whitening agents within 1 months.
- •- Previous laser treatment, chemical peels or transepidermal whitening agents within 3 months
研究者
相似试验
招募中
不适用
Clinical evaluation for the effects of intraocular tissue plasminogen activator administration in various eye diseasesVarious eye diseasesJPRN-UMIN000015726Department of Ophthalmology, Shimane University Faculty of Medicine, Izumo, Japan50
进行中（未招募）
不适用
Evaluation of safety and efficacy of intravitreal bevacizumab for macular edema, retinal or choroidal neovascularization or neovascular glaucoma - NDMacular oedemaMedDRA version: 6.1Level: HLGTClassification code 10047060EUCTR2006-002351-33-ITAZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA
招募中
不适用
Study of the efficacy and safety of intra-retinal arterial fibrinolysis for central retinal artery occlusioCentral Retinal Artery Occlusion(CRAO)JPRN-UMIN000022972Yokohama City University10
进行中（未招募）
不适用
Evaluation of efficacy and safety of Intravitreal bevacizumab versus intravitreal bevacizumab combined with juxtascleral anecortave acetate for the treatment exudative age-related macular degeneration - IVB JSAEUCTR2006-003170-99-ITIVERSITA DEGLI STUDI DI UDINE
已完成
不适用
Formulation and clinical evaluation of the brightening effect of Licorice and Cidr mask on the skiIRCT20200128046288N6Ahvaz University of Medical Sciences48